Association of organophosphate pesticide exposure and paraoxonase with birth outcome in mexican-american women

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Harley, Kim G ^a   Huen, Karen ^a   Schall, Raul Aguilar ^a   Holland, Nina T ^a   Bradman, Asa ^a   Barr, Dana Boyd ^b   Eskenazi, Brenda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANEDIOL DERIVATIVE; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ORGANOPHOSPHATE PESTICIDE; ORGANOPHOSPHORUS COMPOUND; PESTICIDE;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; COHORT ANALYSIS; ENZYME ACTIVITY; FEMALE; GENOTYPE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HISPANIC; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MEDICAL RECORD REVIEW; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RURAL AREA; UMBILICAL CORD BLOOD; UNITED STATES; URINALYSIS; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; GENETICS; MALE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; URINE;

ADULT; ARYLDIALKYLPHOSPHATASE; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MATERNAL EXPOSURE; MEXICAN AMERICANS; ORGANOPHOSPHORUS COMPOUNDS; PESTICIDES; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 80052334311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023923     Document Type: Article

References (39)

1. Keily T, Donaldson D, Grube A, (2004) Pesticides Industry Sales and Usage: 2000 and 2001 Market Estimates Washington, DC US Environmental Protection Agency.
2. Muto MA, Lobelle F Jr, Bidanset JH, Wurpel JN, (1992) Embryotoxicity and neurotoxicity in rats associated with prenatal exposure to DURSBAN. Vet Hum Toxicol 34: 498-501.
3. Breslin W, Liberacki A, Dittenber D, Quast J, (1996) Evaluation of the developmental and reproductive toxicity of chlorpyrifos in the rat. Fundamental and Applied Toxicology 29: 119-130.
4. Chanda SM, Harp P, Liu J, Pope CN, (1995) Comparative developmental and maternal neurotoxicity following acute gestational exposure to chlorpyrifos in rats. J Toxicol Environ Health 44: 189-202.
5. Maurissen JP, Hoberman AM, Garman RH, Hanley TR Jr, (2000) Lack of selective developmental neurotoxicity in rat pups from dams treated by gavage with chlorpyrifos. Toxicol Sci 57: 250-263.
6. Spyker JM, Avery DL, (1977) Neurobehavioral effects of prenatal exposure to the organophosphate Diazinon in mice. J Toxicol Environ Health 3: 989-1002.
7. Srivastava MK, Raizada RB, (1996) Development effect of technical dimethoate in rats: maternal and fetal toxicity evaluation. Indian J Exp Biol 34: 329-333.
8. Qiao D, Seidler FJ, Padilla S, Slotkin TA, (2002) Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period? Environ Health Perspect 110: 1097-1103.
9. Whyatt RM, Rauh V, Barr DB, Camann DE, Andrews HF, et al. (2004) Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ Health Perspect 112: 1125-1132.
10. Barr DB, Ananth CV, Yan X, Lashley S, Smulian JC, et al. (2010) Pesticide concentrations in maternal and umbilical cord sera and their relation to birth outcomes in a population of pregnant women and newborns in New Jersey. Sci Total Environ 408: 790-795.
11. Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, et al. (2007) Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 61: 243-250.
12. Eskenazi B, Harley K, Bradman A, Weltzien E, Jewell NP, et al. (2004) Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect 112: 1116-1124.
13. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, et al. (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8: 1-12.
14. Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, et al. (2010) Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact 187: 355-361.
15. Aviram M, Rosenblat M, (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37: 1304-1316.
16. Li HL, Liu DP, Liang CC, (2003) Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 81: 766-779.
17. Stoltz DA, Ozer EA, Taft PJ, Barry M, Liu L, et al. (2008) Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1. J Clin Invest 118: 3123-3131.
18. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, et al. (2000) Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10: 767-779.
19. Richter R, Jampsa R, Jarvik G, Costa LG, Furlong CE, (2004) Determination of Paraoxonase 1 (PON1) Status and Genotypes at Specific Polymorphic Sites. In: Maines M, editors. Current Protocols in Toxicology Hoboken, NJ Wiley and Sons pp. 4.12.11-14.12.19.
20. Huen K, Richter R, Furlong C, Eskenazi B, Holland N, (2009) Validation of PON1 enzyme activity assays for longitudinal studies. Clin Chim Acta 402: 67-74.
21. Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, et al. (2006) PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 16: 183-190.
22. Deakin SP, James RW, (2004) Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 107: 435-447.
23. Costa LG, Cole TB, Jarvik GP, Furlong CE, (2003) Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 54: 371-392.
24. Deakin S, Leviev I, Brulhart-Meynet MC, James RW, (2003) Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position- 107, implicating the Sp1 transcription factor. Biochem J 372: 643-649.
25. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, et al. (2004) In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 112: 388-391.
26. Moreno-Banda G, Blanco-Munoz J, Lacasana M, Rothenberg SJ, Aguilar-Garduno C, et al. (2009) Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight. Sci Total Environ 407: 5478-5485.
27. Bravo R, Driskell WJ, Whitehead RD Jr, Needham LL, Barr DB, (2002) Quantitation of dialkyl phosphate metabolites of organophosphate pesticides in human urine using GC-MS-MS with isotopic internal standards. J Anal Toxicol 26: 245-252.
28. Bradman A, Eskenazi B, Barr D, Bravo R, Castorina R, et al. (2005) Organophosphate urinary metabolite levels during pregnancy and after delivery in women living in an agricultural community. Environ Health Perspect 113: 1802-1807.
29. Holland N, Furlong C, Bastaki M, Richter R, Bradman A, et al. (2006) Paraoxonase polymorphisms, haplotypes, and enzyme activity in latino mothers and newborns. Environ Health Perspect 114: 985-991.
30. Connelly PW, Maguire GF, Picardo CM, Teiber JF, Draganov D, (2008) Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma. J Lipid Res 49: 245-250.
31. Kujiraoka T, Oka T, Ishihara M, Egashira T, Fujioka T, et al. (2000) A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration. J Lipid Res 41: 1358-1363.
32. Roy AC, Loke DF, Saha N, Viegas OA, Tay JS, et al. (1994) Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study. Gynecol Obstet Invest 38: 10-13.
33. Chen D, Hu Y, Chen C, Yang F, Fang Z, et al. (2004) Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 15: 466-470.
34. Lawlor DA, Gaunt TR, Hinks LJ, Davey Smith G, Timpson N, et al. (2006) The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study. Paediatr Perinat Epidemiol 20: 244-250.
35. Min J, Park H, Park B, Kim YJ, Park J, et al. (2006) Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birthweights. Reprod Toxicol 22: 418-424.
36. Ryckman KK, Morken NH, White MJ, Velez DR, Menon R, et al. (2010) Maternal and fetal genetic associations of PTGER3 and PON1 with preterm birth. PLoS One 5: e9040.
37. Weerasekera G, Smith K, Quirós-Alcalá L, Fernandez C, Bradman A, et al. (2009) A mass spectrometry-based method to measure dialkylphosphate degradation products of organophosphorous insecticides in dust and orange juice. Journal of Environmental Monitoring 11: 1345-1351.
38. Huen K, Barcellos L, Beckman K, Rose S, Eskenazi B, et al. (In Press.) Effects of PON Polymorphisms and Haplotypes on Molecular Phenotype in Mexican-American Mothers and Children. Environmental and Molecular Mutagenesis.
39. Eskenazi B, Huen K, Marks A, Harley K, Bradman A, et al. (2010) PON1 and Neurodevelopment in Children from the CHAMACOS Study Exposed to Organophosphate Pesticides in Utero. Environ Health Perspect.